Diabetes is most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysis

G Corona, A Pizzocaro, W Vena, G Rastrelli… - Reviews in Endocrine …, 2021 - Springer
The presence of SARS-CoV-2 was officially documented in Europe at the end of February
2020. Despite many observations, the real impact of COVID-19 in the European Union (EU) …

[HTML][HTML] Metformin to decrease COVID-19 severity and mortality: Molecular mechanisms and therapeutic potential

O Kamyshnyi, V Matskevych, T Lenchuk… - Biomedicine & …, 2021 - Elsevier
The COVID-19 pandemic caused by the coronavirus SARS-CoV-2 has become a serious
challenge for medicine and science. Analysis of the molecular mechanisms associated with …

Optimization in the context of COVID-19 prediction and control: A literature review

E Jordan, DE Shin, S Leekha, S Azarm - Ieee Access, 2021 - ieeexplore.ieee.org
This paper presents an overview of some key results from a body of optimization studies that
are specifically related to COVID-19, as reported in the literature during 2020-2021. As …

[HTML][HTML] COVID-19 and diabetes—Two giants colliding: From pathophysiology to management

MC Pelle, I Zaffina, M Provenzano… - Frontiers in …, 2022 - frontiersin.org
Since December 2019, a new coronavirus, called severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has spread around the world, causing the coronavirus 2019 …

[HTML][HTML] Stress Hyperglycemia, diabetes mellitus and COVID-19 infection: risk factors, clinical outcomes and post-discharge implications

A Gerganova, Y Assyov, Z Kamenov - Frontiers in Clinical Diabetes …, 2022 - frontiersin.org
The novel severe acute respiratory distress syndrome-coronavirus 2 (SARS-CoV-2) has
caused one of the most substantial pandemics that has affected humanity in the last century …

The management of type 2 diabetes before, during and after Covid-19 infection: what is the evidence?

L Czupryniak, D Dicker, R Lehmann, M Prázný… - Cardiovascular …, 2021 - Springer
Patients with Covid-19 place new challenges on the management of type 2 diabetes,
including the questions of whether glucose-lowering therapy should be adjusted during …

Hospital management of hyperglycemia in the context of COVID-19: evidence-based clinical considerations

TB Mendes, AB Câmara-de-Souza… - Diabetology & Metabolic …, 2022 - Springer
The COVID-19 pandemic led to an unprecedented crisis, and early on, it has been shown
that diabetes is an important risk factor for complications and mortality in infected patients, as …

[HTML][HTML] In vitro study on antidiabetic and antihypertensive activities of ethanolic extract of propolis of Indonesian stingless bee Tetragonula sapiens

S Farida, DK Pratami, M Sahlan, A Mun'im… - Journal of King Saud …, 2023 - Elsevier
The stingless bee, Tetragonula sapiens, is one of the species producing propolis in
Indonesia. To date, there is still limited information about the standard characteristics and …

Diabetes-related acute metabolic emergencies in COVID-19 patients: a systematic review and meta-analysis

VP Papadopoulos, MV Koutroulos, DG Zikoudi… - Diabetology …, 2021 - Springer
Aims COVID-19 is associated with diabetic ketoacidosis (DKA), hyperglycaemic
hyperosmolar state (HHS) and euglycaemic DKA (EDKA); however, evidence regarding …

Bibliometric analysis of diabetes research in relation to the COVID-19 pandemic

BM Gupta, R Pal, L Rohilla, D Dayal - Journal of Diabetology, 2021 - journals.lww.com
Background: Diabetes is a common co-morbid condition that influences morbidity and
mortality in patients with COVID-19 and has been a focus of intense research. However, a …